Mouwasat Medical Services Company, which operates hospitals and medical centers, reported 2014 net profit of SAR 240.1 mln, a 19 percent increase compared to the last year.
| Item | 2013 | 2014 | Change |
|---|---|---|---|
| Revenues | 902.24 | 903.79 | 0.2 % |
| Gross Income | 455.80 | 417.17 | (8.5 %) |
| Operating Income | 222.25 | 233.17 | 4.9 % |
| Net Income | 201.20 | 240.12 | 19.3 % |
| Average Shares | 200.00 | 200.00 | - |
| EPS (Riyals) | 1.01 | 1.20 | 19.3 % |
A net profit of SAR 50.7 mln was reported for Q4-2014 compared to SAR 72.0 mln for Q3.
The company attributed the increase of 2014’s net profit compared to the last year to the continual effective utilization of available resources, the continuous development of medical systems, launching new services and due to the decrease of non-controlling interest from Eastern Medical Services Co located in eastern province, the percentages of ownership in this subsidiary company is 51% by Mouwasat Medical Services and 49% of the equity by non-controlling interest, has not achieved expected revenue and due to the capital gains from sale and swapping of lands amounting to SAR 23.9 million.
Q4-2014’s net profit increase compared to the same period last year was attributed to the capital gain from swapping land owned by the company with a land owned by Ministry Of Justice nearby Mouwasat Hospital Dammam amounting to SAR 2.3 million, and due to the decrease of non-controlling interest from Eastern Medical Services Co located in eastern province, the percentages of ownership of this subsidiary company 51% by Mouwasat Medical Services and 49% of the equity by non-controlling interest, has not achieved expected revenue. The decrease of the gross profits and operating income for the current quarter
compared to the same quarter of the previous year due to the inability of Mouwasat hospital Qatif which owned by Eastern Medical Services Company to achieve the expected operating results during the quarter, and also due to the negative results from operations of Mouwasat Hospital Riyadh which commenced its operations, Nov. 29, 2014 amounting to SAR 3.6 million.
Q4-2014’s net profit decline compared to Q3-2014 was attributed to:
1. Previous quarter net profit included capital gains of SAR 21.7 million as a result of sale of land was owned in Dhahran.
2. The negative results from operations of Mouwasat Hospital-Riyadh which commenced its operations, Nov. 29, 2014 amounting to SAR 3.6 million.
The decline of operating income for the current quarter compared to the previous quarter due to negative results from operation of Mouwasat Hospital-Riyadh which commenced its operations, Nov. 29, 2014 amounting to SAR 3.6 million.
| Item | Q4 2013 | Q4 2014 | Change |
|---|---|---|---|
| Revenues | 242.64 | 247.18 | 1.9 % |
| Gross Income | 124.17 | 117.49 | (5.4 %) |
| Operating Income | 55.21 | 52.86 | (4.3 %) |
| Net Income | 50.42 | 50.75 | 0.7 % |
| Average Shares | 200.00 | 200.00 | - |
| EPS (Riyals) | 0.25 | 0.25 | 0.7 % |
| Item | Q3 2014 | Q4 2014 | Change |
|---|---|---|---|
| Revenues | 230.47 | 247.18 | 7.2 % |
| Gross Income | 113.02 | 117.49 | 4.0 % |
| Operating Income | 54.13 | 52.86 | (2.3 %) |
| Net Income | 71.99 | 50.75 | (29.5 %) |
| Average Shares | 200.00 | 200.00 | - |
| EPS (Riyals) | 0.36 | 0.25 | (29.5 %) |
| Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
|---|---|---|---|---|---|---|---|
| Q1 2005 | - | - | - | - | - | - | - |
| Q2 2005 | - | - | - | - | - | - | - |
| Q3 2005 | - | - | - | - | - | - | - |
| Q4 2005 | - | - | - | - | - | - | - |
| 2005 | 267.39 | - | 108.50 | - | 53.65 | - | 0.27 |
| Q1 2006 | - | - | - | - | - | - | - |
| Q2 2006 | - | - | - | - | - | - | - |
| Q3 2006 | - | - | - | - | - | - | - |
| Q4 2006 | - | - | - | - | - | - | - |
| 2006 | 342.93 | 28.3 % | 135.46 | 24.8 % | 63.23 | 17.9 % | 0.32 |
| Q1 2007 | - | - | - | - | - | - | - |
| Q2 2007 | - | - | - | - | - | - | - |
| Q3 2007 | - | - | - | - | - | - | - |
| Q4 2007 | - | - | - | - | - | - | - |
| 2007 | 400.67 | 16.8 % | 173.39 | 28.0 % | 88.76 | 40.4 % | 0.44 |
| Q1 2008 | 113.83 | - | 52.37 | - | 25.90 | - | 0.13 |
| Q2 2008 | 118.48 | - | 53.79 | - | 26.63 | - | 0.13 |
| Q3 2008 | 104.92 | - | 47.23 | - | 20.47 | - | 0.10 |
| Q4 2008 | 117.32 | - | 47.51 | - | 24.07 | - | 0.12 |
| 2008 | 454.55 | 13.4 % | 200.90 | 15.9 % | 97.07 | 9.4 % | 0.49 |
| Q1 2009 | 124.60 | 9.5 % | 56.25 | 7.4 % | 26.55 | 2.5 % | 0.13 |
| Q2 2009 | 140.62 | 18.7 % | 67.77 | 26.0 % | 34.03 | 27.8 % | 0.17 |
| Q3 2009 | 115.21 | 9.8 % | 54.05 | 14.4 % | 21.88 | 6.9 % | 0.11 |
| Q4 2009 | 137.16 | 16.9 % | 49.94 | 5.1 % | 24.58 | 2.1 % | 0.12 |
| 2009 | 517.60 | 13.9 % | 228.00 | 13.5 % | 107.04 | 10.3 % | 0.54 |
| Q1 2010 | 143.79 | 15.4 % | 68.04 | 21.0 % | 32.37 | 21.9 % | 0.16 |
| Q2 2010 | 148.78 | 5.8 % | 71.36 | 5.3 % | 34.77 | 2.2 % | 0.17 |
| Q3 2010 | 134.72 | 16.9 % | 63.30 | 17.1 % | 23.14 | 5.8 % | 0.12 |
| Q4 2010 | 160.20 | 16.8 % | 74.36 | 48.9 % | 28.28 | 15.1 % | 0.14 |
| 2010 | 587.49 | 13.5 % | 277.05 | 21.5 % | 118.57 | 10.8 % | 0.59 |
| Q1 2011 | 166.82 | 16.0 % | 84.05 | 23.5 % | 39.14 | 20.9 % | 0.20 |
| Q2 2011 | 164.93 | 10.9 % | 76.76 | 7.6 % | 40.49 | 16.4 % | 0.20 |
| Q3 2011 | 156.92 | 16.5 % | 74.10 | 17.1 % | 33.71 | 45.7 % | 0.17 |
| Q4 2011 | 189.77 | 18.5 % | 89.09 | 19.8 % | 34.72 | 22.8 % | 0.17 |
| 2011 | 678.44 | 15.5 % | 324.00 | 16.9 % | 148.06 | 24.9 % | 0.74 |
| Q1 2012 | 195.57 | 17.2 % | 94.32 | 12.2 % | 46.34 | 18.4 % | 0.23 |
| Q2 2012 | 200.62 | 21.6 % | 93.28 | 21.5 % | 47.26 | 16.7 % | 0.24 |
| Q3 2012 | 187.28 | 19.3 % | 84.01 | 13.4 % | 35.44 | 5.1 % | 0.18 |
| Q4 2012 | 213.04 | 12.3 % | 101.10 | 13.5 % | 42.56 | 22.6 % | 0.21 |
| 2012 | 796.51 | 17.4 % | 372.71 | 15.0 % | 171.60 | 15.9 % | 0.86 |
| Q1 2013 | 219.23 | 12.1 % | 110.39 | 17.0 % | 52.52 | 13.3 % | 0.26 |
| Q2 2013 | 228.74 | 14.0 % | 116.90 | 25.3 % | 54.16 | 14.6 % | 0.27 |
| Q3 2013 | 211.63 | 13.0 % | 104.34 | 24.2 % | 44.11 | 24.5 % | 0.22 |
| Q4 2013 | 242.64 | 13.9 % | 124.17 | 22.8 % | 50.42 | 18.4 % | 0.25 |
| 2013 | 902.24 | 13.3 % | 455.80 | 22.3 % | 201.20 | 17.3 % | 1.01 |
| Q1 2014 | 243.54 | 11.1 % | 124.18 | 12.5 % | 57.94 | 10.3 % | 0.29 |
| Q2 2014 | 244.25 | 6.8 % | 124.14 | 6.2 % | 59.44 | 9.8 % | 0.30 |
| Q3 2014 | 230.47 | 8.9 % | 113.02 | 8.3 % | 71.99 | 63.2 % | 0.36 |
| Q4 2014 | 247.18 | 1.9 % | 117.49 | (5.4 %) | 50.75 | 0.7 % | 0.25 |
| 2014 | 903.79 | 0.2 % | 417.17 | (8.5 %) | 240.12 | 19.3 % | 1.20 |
| Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
|---|---|---|---|---|---|---|---|
| 2005 | 267.39 | - | 108.50 | - | 53.65 | - | 0.27 |
| 2006 | 342.93 | 28.3 % | 135.46 | 24.8 % | 63.23 | 17.9 % | 0.32 |
| 2007 | 400.67 | 16.8 % | 173.39 | 28.0 % | 88.76 | 40.4 % | 0.44 |
| 2008 | 454.55 | 13.4 % | 200.90 | 15.9 % | 97.07 | 9.4 % | 0.49 |
| 2009 | 517.60 | 13.9 % | 228.00 | 13.5 % | 107.04 | 10.3 % | 0.54 |
| 2010 | 587.49 | 13.5 % | 277.05 | 21.5 % | 118.57 | 10.8 % | 0.59 |
| 2011 | 678.44 | 15.5 % | 324.00 | 16.9 % | 148.06 | 24.9 % | 0.74 |
| 2012 | 796.51 | 17.4 % | 372.71 | 15.0 % | 171.60 | 15.9 % | 0.86 |
| 2013 | 902.24 | 13.3 % | 455.80 | 22.3 % | 201.20 | 17.3 % | 1.01 |
| 2014 | 903.79 | 0.2 % | 417.17 | (8.5 %) | 240.12 | 19.3 % | 1.20 |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2005 | - | - | - |
| Q2 2005 | - | - | - |
| Q3 2005 | - | - | - |
| Q4 2005 | - | - | - |
| 2005 | 40.58 % | 28.06 % | 20.06 % |
| Q1 2006 | - | - | - |
| Q2 2006 | - | - | - |
| Q3 2006 | - | - | - |
| Q4 2006 | - | - | - |
| 2006 | 39.50 % | 26.05 % | 18.44 % |
| Q1 2007 | - | - | - |
| Q2 2007 | - | - | - |
| Q3 2007 | - | - | - |
| Q4 2007 | - | - | - |
| 2007 | 43.28 % | 31.24 % | 22.15 % |
| Q1 2008 | - | - | - |
| Q2 2008 | - | - | - |
| Q3 2008 | - | - | - |
| Q4 2008 | 44.20 % | 30.76 % | 21.36 % |
| 2008 | 44.20 % | 30.76 % | 21.36 % |
| Q1 2009 | 44.01 % | 30.89 % | 21.00 % |
| Q2 2009 | 44.88 % | 32.07 % | 21.57 % |
| Q3 2009 | 45.32 % | 32.67 % | 21.40 % |
| Q4 2009 | 44.05 % | 30.06 % | 20.68 % |
| 2009 | 44.05 % | 30.06 % | 20.68 % |
| Q1 2010 | 44.67 % | 30.72 % | 21.03 % |
| Q2 2010 | 44.66 % | 30.02 % | 20.85 % |
| Q3 2010 | 44.76 % | 28.94 % | 20.35 % |
| Q4 2010 | 47.16 % | 30.15 % | 20.18 % |
| 2010 | 47.16 % | 30.15 % | 20.18 % |
| Q1 2011 | 48.00 % | 29.97 % | 20.53 % |
| Q2 2011 | 47.63 % | 29.54 % | 20.91 % |
| Q3 2011 | 47.66 % | 30.31 % | 21.83 % |
| Q4 2011 | 47.76 % | 30.40 % | 21.82 % |
| 2011 | 47.76 % | 30.40 % | 21.82 % |
| Q1 2012 | 47.27 % | 30.32 % | 21.95 % |
| Q2 2012 | 47.22 % | 30.30 % | 21.81 % |
| Q3 2012 | 46.65 % | 28.88 % | 21.18 % |
| Q4 2012 | 46.79 % | 28.28 % | 21.54 % |
| 2012 | 46.79 % | 28.28 % | 21.54 % |
| Q1 2013 | 47.40 % | 28.13 % | 21.68 % |
| Q2 2013 | 48.62 % | 28.20 % | 21.77 % |
| Q3 2013 | 49.59 % | 28.72 % | 22.16 % |
| Q4 2013 | 50.52 % | 29.11 % | 22.30 % |
| 2013 | 50.52 % | 29.11 % | 22.30 % |
| Q1 2014 | 50.68 % | 28.86 % | 22.30 % |
| Q2 2014 | 50.62 % | 28.77 % | 22.49 % |
| Q3 2014 | 50.53 % | 28.82 % | 22.70 % |
| Q4 2014 | 49.60 % | 28.54 % | 22.40 % |
| 2014 | 46.16 % | 30.49 % | 23.92 % |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| 2005 | 40.58 % | 28.06 % | 20.06 % |
| 2006 | 39.50 % | 26.05 % | 18.44 % |
| 2007 | 43.28 % | 31.24 % | 22.15 % |
| 2008 | 44.20 % | 30.76 % | 21.36 % |
| 2009 | 44.05 % | 30.06 % | 20.68 % |
| 2010 | 47.16 % | 30.15 % | 20.18 % |
| 2011 | 47.76 % | 30.40 % | 21.82 % |
| 2012 | 46.79 % | 28.28 % | 21.54 % |
| 2013 | 50.52 % | 29.11 % | 22.30 % |
| 2014 | 46.16 % | 30.49 % | 23.92 % |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2005 | - | - | - |
| Q2 2005 | - | - | - |
| Q3 2005 | - | - | - |
| Q4 2005 | - | - | - |
| Q1 2006 | - | - | - |
| Q2 2006 | - | - | - |
| Q3 2006 | - | - | - |
| Q4 2006 | - | - | - |
| Q1 2007 | - | - | - |
| Q2 2007 | - | - | - |
| Q3 2007 | - | - | - |
| Q4 2007 | - | - | - |
| Q1 2008 | 46.01 % | 31.17 % | 22.75 % |
| Q2 2008 | 45.40 % | 31.49 % | 22.48 % |
| Q3 2008 | 45.02 % | 29.90 % | 19.51 % |
| Q4 2008 | 40.49 % | 30.38 % | 20.52 % |
| Q1 2009 | 45.14 % | 31.63 % | 21.31 % |
| Q2 2009 | 48.19 % | 35.49 % | 24.20 % |
| Q3 2009 | 46.91 % | 32.66 % | 18.99 % |
| Q4 2009 | 36.41 % | 20.87 % | 17.92 % |
| Q1 2010 | 47.32 % | 33.89 % | 22.51 % |
| Q2 2010 | 47.96 % | 32.68 % | 23.37 % |
| Q3 2010 | 46.98 % | 27.76 % | 17.18 % |
| Q4 2010 | 46.42 % | 26.45 % | 17.65 % |
| Q1 2011 | 50.38 % | 32.72 % | 23.46 % |
| Q2 2011 | 46.54 % | 30.78 % | 24.55 % |
| Q3 2011 | 47.22 % | 31.20 % | 21.48 % |
| Q4 2011 | 46.95 % | 27.37 % | 18.29 % |
| Q1 2012 | 48.23 % | 32.08 % | 23.69 % |
| Q2 2012 | 46.49 % | 30.64 % | 23.56 % |
| Q3 2012 | 44.86 % | 25.18 % | 18.92 % |
| Q4 2012 | 47.46 % | 25.28 % | 19.98 % |
| Q1 2013 | 50.35 % | 31.12 % | 23.96 % |
| Q2 2013 | 51.11 % | 30.61 % | 23.68 % |
| Q3 2013 | 49.30 % | 27.68 % | 20.84 % |
| Q4 2013 | 51.18 % | 27.14 % | 20.78 % |
| Q1 2014 | 50.99 % | 29.94 % | 23.79 % |
| Q2 2014 | 50.83 % | 30.16 % | 24.34 % |
| Q3 2014 | 49.04 % | 27.98 % | 21.82 % |
| Q4 2014 | 47.53 % | 26.09 % | 19.64 % |
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2005 | - | - | - | - |
| Q2 2005 | - | - | - | - |
| Q3 2005 | - | - | - | - |
| Q4 2005 | - | - | - | - |
| Q1 2006 | - | - | - | - |
| Q2 2006 | - | - | - | - |
| Q3 2006 | - | - | - | - |
| Q4 2006 | - | - | - | - |
| Q1 2007 | - | - | - | - |
| Q2 2007 | - | - | - | - |
| Q3 2007 | - | - | - | - |
| Q4 2007 | - | - | - | - |
| Q1 2008 | 200.00 | - | - | 1.90 |
| Q2 2008 | 200.00 | - | - | 1.92 |
| Q3 2008 | 200.00 | - | - | 2.02 |
| Q4 2008 | 200.00 | 0.49 | 0.49 | 2.05 |
| Q1 2009 | 200.00 | 0.49 | 0.49 | 2.18 |
| Q2 2009 | 200.00 | 0.53 | 0.53 | 2.27 |
| Q3 2009 | 200.00 | 0.53 | 0.53 | 2.28 |
| Q4 2009 | 200.00 | 0.54 | 0.54 | 2.40 |
| Q1 2010 | 200.00 | 0.56 | 0.56 | 2.56 |
| Q2 2010 | 200.00 | 0.57 | 0.57 | 2.61 |
| Q3 2010 | 200.00 | 0.57 | 0.57 | 2.72 |
| Q4 2010 | 200.00 | 0.59 | 0.59 | 2.86 |
| Q1 2011 | 200.00 | 0.63 | 0.63 | 3.06 |
| Q2 2011 | 200.00 | 0.66 | 0.66 | 3.01 |
| Q3 2011 | 200.00 | 0.71 | 0.71 | 3.18 |
| Q4 2011 | 200.00 | 0.74 | 0.74 | 3.34 |
| Q1 2012 | 200.00 | 0.78 | 0.78 | 3.57 |
| Q2 2012 | 200.00 | 0.81 | 0.81 | 3.44 |
| Q3 2012 | 200.00 | 0.82 | 0.82 | 3.61 |
| Q4 2012 | 200.00 | 0.86 | 0.86 | 3.82 |
| Q1 2013 | 200.00 | 0.89 | 0.89 | 4.08 |
| Q2 2013 | 200.00 | 0.92 | 0.92 | 3.98 |
| Q3 2013 | 200.00 | 0.97 | 0.97 | 4.20 |
| Q4 2013 | 200.00 | 1.01 | 1.01 | 4.44 |
| Q1 2014 | 200.00 | 1.03 | 1.03 | 4.73 |
| Q2 2014 | 200.00 | 1.06 | 1.06 | 4.53 |
| Q3 2014 | 200.00 | 1.20 | 1.09 | 4.89 |
| Q4 2014 | 200.00 | 1.20 | 1.08 | 5.14 |
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| 2005 | 200.00 | 0.27 | 0.27 | 1.25 |
| 2006 | 200.00 | 0.32 | 0.32 | 1.49 |
| 2007 | 200.00 | 0.44 | 0.44 | 1.77 |
| 2008 | 200.00 | 0.49 | 0.49 | 2.05 |
| 2009 | 200.00 | 0.54 | 0.54 | 2.40 |
| 2010 | 200.00 | 0.59 | 0.59 | 2.86 |
| 2011 | 200.00 | 0.74 | 0.74 | 3.34 |
| 2012 | 200.00 | 0.86 | 0.86 | 3.82 |
| 2013 | 200.00 | 1.01 | 1.01 | 4.44 |
| 2014 | 200.00 | 1.20 | 1.08 | 5.14 |
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| Q1 2005 | - | - | - |
| Q2 2005 | - | - | - |
| Q3 2005 | - | - | - |
| Q4 2005 | - | - | - |
| Q1 2006 | - | - | - |
| Q2 2006 | - | - | - |
| Q3 2006 | - | - | - |
| Q4 2006 | - | - | - |
| Q1 2007 | - | - | - |
| Q2 2007 | - | - | - |
| Q3 2007 | - | - | - |
| Q4 2007 | - | - | - |
| Q1 2008 | - | - | - |
| Q2 2008 | - | - | - |
| Q3 2008 | - | - | - |
| Q4 2008 | - | - | - |
| Q1 2009 | - | - | - |
| Q2 2009 | - | - | - |
| Q3 2009 | 14.20 | 14.20 | 3.31 |
| Q4 2009 | 14.31 | 14.31 | 3.19 |
| Q1 2010 | 13.68 | 13.68 | 3.02 |
| Q2 2010 | 14.64 | 14.64 | 3.19 |
| Q3 2010 | 14.75 | 14.75 | 3.11 |
| Q4 2010 | 15.18 | 15.18 | 3.15 |
| Q1 2011 | 13.52 | 13.52 | 2.77 |
| Q2 2011 | 16.08 | 16.08 | 3.50 |
| Q3 2011 | 13.29 | 13.29 | 2.96 |
| Q4 2011 | 15.92 | 15.92 | 3.53 |
| Q1 2012 | 16.83 | 16.83 | 3.66 |
| Q2 2012 | 13.89 | 13.89 | 3.27 |
| Q3 2012 | 15.57 | 15.57 | 3.53 |
| Q4 2012 | 15.66 | 15.66 | 3.52 |
| Q1 2013 | 18.00 | 18.00 | 3.92 |
| Q2 2013 | 18.62 | 18.62 | 4.32 |
| Q3 2013 | 21.21 | 21.21 | 4.88 |
| Q4 2013 | 22.86 | 22.86 | 5.18 |
| Q1 2014 | 21.78 | 21.78 | 4.75 |
| Q2 2014 | 24.19 | 24.19 | 5.66 |
| Q3 2014 | 26.21 | 28.82 | 6.43 |
| Q4 2014 | 25.71 | 28.55 | 6.01 |
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| 2005 | - | - | - |
| 2006 | - | - | - |
| 2007 | - | - | - |
| 2008 | - | - | - |
| 2009 | 14.31 | 14.31 | 3.19 |
| 2010 | 15.18 | 15.18 | 3.15 |
| 2011 | 15.92 | 15.92 | 3.53 |
| 2012 | 15.66 | 15.66 | 3.52 |
| 2013 | 22.86 | 22.86 | 5.18 |
| 2014 | 25.71 | 28.55 | 6.01 |
Q4 2014
2014
| Period | Medical Services | Pharmaceutical Products | Administration Fees |
|---|---|---|---|
| Q1 2008 | 86.60 | 26.81 | 0.43 |
| Q2 2008 | 91.71 | 26.38 | 0.40 |
| Q3 2008 | 84.21 | 20.23 | 0.47 |
| Q4 2008 | 84.07 | 31.65 | 1.61 |
| Q1 2009 | 94.61 | 29.63 | 0.36 |
| Q2 2009 | 105.22 | 28.44 | 6.97 |
| Q3 2009 | 92.73 | 26.15 | (3.67) |
| Q4 2009 | 103.72 | 33.04 | 0.40 |
| Q1 2010 | 109.41 | 32.47 | 1.92 |
| Q2 2010 | 114.73 | 34.05 | - |
| Q3 2010 | 102.85 | 31.87 | - |
| Q4 2010 | 118.91 | 41.29 | - |
| Q1 2011 | 129.63 | 37.19 | - |
| Q2 2011 | 128.04 | 36.89 | - |
| Q3 2011 | 123.09 | 33.84 | - |
| Q4 2011 | 149.24 | 40.52 | - |
| Q1 2012 | 155.38 | 40.19 | - |
| Q2 2012 | 159.24 | 41.38 | - |
| Q3 2012 | 149.51 | 37.77 | - |
| Q4 2012 | 168.11 | 44.93 | - |
| Q1 2013 | 177.18 | 42.05 | - |
| Q2 2013 | 186.71 | 42.02 | - |
| Q3 2013 | 172.61 | 39.02 | - |
| Q4 2013 | 182.05 | 45.21 | - |
| Q1 2014 | 196.67 | 46.87 | - |
| Q2 2014 | 198.14 | 46.10 | - |
| Q3 2014 | 186.70 | 43.78 | - |
| Q4 2014 | 137.05 | 48.48 | - |
| Period | Medical Services | Pharmaceutical Products | Administration Fees |
|---|---|---|---|
| 2005 | 218.74 | 46.93 | 1.72 |
| 2006 | 275.14 | 66.36 | 1.42 |
| 2007 | 275.14 | 88.92 | 2.32 |
| 2008 | 346.58 | 105.06 | 2.91 |
| 2009 | 396.28 | 117.25 | 4.07 |
| 2010 | 445.90 | 139.68 | 1.92 |
| 2011 | 530.00 | 148.44 | - |
| 2012 | 632.24 | 164.27 | - |
| 2013 | 718.55 | 168.30 | - |
| 2014 | 718.55 | 185.23 | - |
| Item | Q4 2014 (e) | Q4 2014 (a) | Change |
|---|---|---|---|
| Average | 49.40 | 50.75 | 2.73 % |
| Item | Q4 2014 (e) | Q4 2014 (a) | Change |
|---|---|---|---|
| OSOOL AND BAKHEET | 49.40 | 50.75 | 2.7 % |
| Current | |
| Market Cap (M Riyal) | 24,320.00 |
| Enterprise Value (EV) (M) | 24,972.78 |
| Shares Outstanding ((M)) | 200.00 |
| EPS ( Riyal) (TTM) | 3.31 |
| Book Value (BV) ( Riyal) | 17.24 |
| Par Value ( Riyal) | 10.00 |
| Adjusted P/E (Last12) | 36.70 |
| P/E (TTM) | 36.70 |
| Price/book | 7.05 |
| Return on Average Assets (%) (TTM) | 13.0 |
| Return on Average Equity (%) (TTM) | 20.3 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}